A majority of healthcare technology leaders believe artificial intelligence is no longer just a buzzword—it’s delivering measurable business value. According to a newly released report by KPMG— Global Tech Report: Healthcare Insights, 66% of health tech executives say their organisations are already seeing tangible returns from multiple AI use cases. Based on inputs from 122 global healthcare tech leaders and drawn from a larger survey...

In a surprising escalation, US President Donald Trump has warned of imposing steep tariffs on the pharma sector—just hours after exempting the category from his sweeping 26 per cent reciprocal tariff on Indian imports. Speaking to reporters aboard Air Force One, Trump said that pharmaceuticals are being reviewed as a separate category and that tariffs “at levels you haven’t really seen before” could be...

The healthcare industry is undergoing a digital transformation, and at the heart of this shift lies a powerful enabler—cloud computing. As healthcare systems face growing pressures to deliver quality care, reduce costs, and improve operational efficiency, cloud technology is emerging as a critical solution for the sector’s evolving needs. Seamless Access to Patient Records  Across hospitals, clinics, and care networks, the cloud is revolutionising how patient...

Sun Pharma and Zydus Pharmaceuticals have initiated recalls of their medications in the US due to manufacturing and quality concerns, as flagged by the US Food and Drug Administration (USFDA). Sun Pharma’s New Jersey-based unit is recalling 9,840 bottles of Morphine Sulfate extended-release tablets due to failed dissolution specifications, according to the US health regulator’s latest enforcement report. The company initiated a Class II recall...

Sun Pharmaceutical Industries Ltd, India’s largest drugmaker, has announced the acquisition of US-based oncology and immunotherapy firm Checkpoint Therapeutics Inc. for $355 million (₹3,000 crore) in a strategic move to strengthen its specialty therapy portfolio. This marks Sun Pharma’s second major acquisition in less than three months as the company seeks to expand its presence in the oncology and dermatology space. Expanding Oncology Portfolio with FDA-Approved...

India’s healthcare sector is undergoing a major transformation, with hospitals leading the charge in infrastructure development, digital health adoption, and increased investment activity. According to the latest report, "Vitals for Growth: Decoding Healthcare Financing and Funding in India," published by the Association of Healthcare Providers India (AHPI) in collaboration with Grant Thornton Bharat, the sector has seen a significant influx of funds driven by...

The Department of Pharmaceuticals has invited Expressions of Interest (EoI) from eligible entities for project funding under the Promotion of Research and Innovation in Pharma MedTech sector (PRIP) scheme. This initiative aims to bolster India’s research and development (R&D) capabilities, positioning the country as a global leader in pharmaceutical and medical technology innovations. PRIP Scheme: Strengthening India’s Pharma MedTech Ecosystem The PRIP scheme, launched on August...

The North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, has taken a groundbreaking step in forensic science by successfully completing a four-week training program on Virtual Autopsy. This initiative makes NEIGRIHMS only the second institution in India to adopt this advanced forensic technique. A Leap in Forensic Science The training program, held from February 10 to March 8, was supported by...

The United States’ proposed tariffs on pharmaceutical imports could severely impact Indian drug manufacturers, increasing production costs and reducing competitiveness, according to industry experts. However, the Indian automobile sector is expected to remain largely unaffected, as the US accounts for a small share of India's auto exports. Impact on India’s Pharmaceutical Sector The US is a critical market for Indian pharmaceutical companies, with nearly 40 percent...

India must revise its clinical trial regulations to capture a larger share of the global clinical research market, taking cues from countries like China and Australia, according to healthcare experts at the BioAsia conference in Telangana. India’s Global Position in Clinical Trials As of 2022, India accounted for just 8% of global clinical trials, compared to China’s 29%, the U.S.’s 25%, and 38% for the rest...